TinyGemsBreaks Archive - Page 114 of 128

WednesdayAug 17, 2022 1:51 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Driving State-of-the-Art Solutions

Cepton (NASDAQ: CPTN) is an innovator pioneering high-performance Micro Motion Technology (“MMT(R)”) lidar solutions. The company recently selected Fabrinet (NYSE: FN), a leader specializing in precision optical, electro-optical, sophisticated electronic PCBA, and electro-mechanical process technologies, to produce its flagship automotive-grade Vista(R)-X90 lidar. The partnership could expedite Cepton’s efforts toward mass-market commercialization of high-performance, high-quality lidar solutions. “The Vista(R)-X90 lidar features Cepton’s patented MMT(R) technology configured to deliver scalable lidar solutions with a superior balance between performance, reliability and cost, as well as Cepton’s proprietary lidar engine ASIC, designed for optical illumination control, detection and signal processing. Vista(R)-X90 will be deployed…

WednesdayAug 17, 2022 10:15 am

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) K5 Deployed at Houston-Based Lubricant Manufacturing Plant

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a Houston manufacturer of premium quality lubricants and associated products for the automotive, industrial and drilling markets has successfully deployed its Knightscope K5 Autonomous Security Robot (“ASR”). The deployment intends to help protect the client’s industrial plant and storage facility in the northeast corner of the city. The announcement reads, “Petrochemical plants pose unique challenges that include threats to the environment, neighboring populations, and site employees’ lives and health. An accidental or intentional incident at such a plant could cause the…

TuesdayAug 16, 2022 1:33 pm

TinyGemsBreaks – QSAM Biosciences Inc. (OTCQB: QSAM) Releases Q2 2022 Financial Report, Corporate Update

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has reported on its financial results for Q2, the period ended June 30, 2022; the company also noted that progress has been shown in its phase 1 clinical program designed to evaluate CycloSam, its proprietary radiopharmaceutical drug candidate for the treatment of metastatic bone cancer. Specifically, the report noted that preliminary evaluation of the first patient dosed in the phase 1 trial suggests promising results with second patient dosing and completion of the first cohort of patients…

TuesdayAug 16, 2022 12:29 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q2 2022 Financial Report, Names New CFO

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting its Q2 2022 financial results for the period ended June 30, 2022; the company also noted key corporate updates. Highlights of the report included news that the company’s $1 billion processing volume is a 40% increase over Q1 processing volume and more than double the same period last year with GBOX revenues for the quarter reaching $7 million, up from $6.4 million from last year at this same time. In addition, the report noted that the company’s recently acquired Sky Financial portfolio showed Q2 processing volume at $769…

TuesdayAug 16, 2022 11:43 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Results of Annual Meeting of Shareholders

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM)”, today announced voting results for each of the matters presented at the company’s annual shareholders’ meeting. There were 71 shareholders represented in person or by proxy, holding 47,019,721 common shares, representing 28.3% of Cybin’s total issued and outstanding common shares as at the record date for the meeting held on Aug. 15, 2022. The announcement details voting results for each matter presented, including the appointment of Zeifmans LLP as auditor and election of directors. Each of the nominees listed in Cybin’s July 13 management information…

TuesdayAug 16, 2022 11:08 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases Financial Results for H1 2022

Flora Growth (NASDAQ: FLGC), a manufacturer and distributor of global cannabis products and brands, is reporting its financial and corporate results for the six months ending June 30, 2022. Highlights of the report include revenue for the company increasing 604% from the same period last year, reaching ~$15 million while gross profit for the company increased to ~$7 million, an increase of 547%. In the report, the company reaffirmed its 2022 revenue guidance of $35 million to $45 million, which represents an increase in projected revenue of between 300% to 400%. “In the first half of 2022, Flora delivered on…

MondayAug 15, 2022 12:33 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Files F-1 Registration

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the NAFTA region, today announced that it has filed a Form F-1 with the SEC. “We are incredibly proud of our team and thank them for their work and dedication to deliver our F-1 registration, which positions us to be able to continue to grow as a public company. Delivering our registration statement puts us in a position to continue to work with the capital markets to foster the growth of our…

MondayAug 15, 2022 12:26 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2022 Financial Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today reported its financial results for the quarter ended June 30, 2022, and provided a clinical update of its anti-cancer drug candidates currently in development. “Within the past six months alone, we have executed on a number of clinical and operational advancements including expanding our global presence with clinical approvals in Spain, France and Switzerland to drive patient enrollment forward, as well as expanding eligibility for patients to participate in our…

MondayAug 15, 2022 12:11 pm

TinyGemsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Entry into Revolving Credit Facility, Launch of Stock Portfolio Tracker

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company today announced its entry into a revolving credit facility as well as the launch of a website that allows investors to track the current value of SRAX’s marketable securities portfolio. “We are working diligently with our auditors to get our 10K filled. As of this date, there are no significant deviations (+/- 3%) on the income statement that we presented in our annual update. Our auditors have told us they believe that we will be…

FridayAug 12, 2022 1:30 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

Aditxt (NASDAQ: ADTX) has sought to address a medical conundrum: approximately 50% of all transplanted organs are rejected by the host’s body within 10-12 years despite a wide array of medical innovations in recent years. This highlights the critical need for a practical, cost-effective solution to harmful immune responses. Aditxt is looking to solve this medical problem “through the creation of immune reprogramming technologies, which are being developed to retrain the immune system to induce tolerance to transplanted organs, self-tissues (autoimmune diseases) and allergens,” a recent article reads. “While still at a pre-clinical stage, ADi(TM) (Apoptotic DNA Immunotherapy), the company’s…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks